In a recent safety communications update, the U.S. Food and Drug Administration (FDA) changed its previous position from 2008 regarding vaginal mesh, and states that serious complications associated with using surgical mesh for transvaginal repair for pelvic organ prolapse (POP) are not rare.
In addition, the FDA also states that it is not clear that transvaginal POP repair with mesh is more effective than non-mesh repair, and patients may be exposed to greater risks. Due to the high number of adverse effects reports received, the FDA has identified surgical mesh for transvaginal repair of POP as an area of continuing concern.
Thirty to fifty percent of women may experience pelvic organ prolapse during their lifetime, a condition that occurs when the tissues that hold pelvic organs become weak or stretched; 2 percent of the women will develop symptoms. When surgical mesh is used for treatment, some women may experience side effects including erosion of the mesh, severe pelvic pain, infection, recurrences of the prolapse and other complications.
If you are experiencing pelvic mesh side effects, a vaginal mesh attorney may be able to help you pursue a claim for compensation. For more information about your legal rights or vaginal mesh lawsuits and litigation, call 1-888-BURNETTI.